Bo Porse is a Professor in Molecular Oncology and the director at the Finsen Laboratory at the Copenhagen University Hospital – Rigshospitalet in Denmark. Bo is a molecular biologist, stem cell scientist and an expert in normal and malignant hematopoiesis. His research is centered on understanding how stem cell behavior shapes the properties of our blood system during steady state and in disease, with the specific aim of identifying novel way to treat aggressive blood cancers. For this he uses the wide arsenal of methodologies available in the field of experimental hematology including long-term culturing of primary hematopoietic and leukemic stem cells, CRISPR editing of primary cells as well as advanced models of human pre-malignant and malignant conditions. Technology-wise his lab has strong expertise in single cell technologies and has invested heavily in the development of the emerging field of single cell proteomics.
Bo holds a PhD in Molecular Biology from the University of Copenhagen.
